AIDS Healthcare Foundation Leaders Support Reducing Vaccine Research
In order to control the spread of HIV/AIDS, funding must be spent on strategies that have been proven effective—such as prevention, routine testing and universal access to treatment—instead of on vaccine research, write two AIDS experts in a Baltimore Sun editorial (baltimoresun.com, 3/23).
Dr. Homayoon Khanlou and Michael Weinstein, chief of medicine and president of the AIDS Healthcare Foundation respectively, pointed to recent vaccine trial failures, such as a Merck trial which may have increased participants’ risk of contracting HIV, as reasons why funding should not be focused on developing an AIDS vaccine.
“Despite this record of failure, the U.S. budget for HIV vaccine research continues to increase…[and] funding for HIV/AIDS care in the U.S. has flat-lined,” they write. “And around the world, millions are dying for lack of access to a 5-cent condom, a $15 HIV test or antiretroviral therapy costing as little as 50 cents a day.”
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Beth Benne, RN, is HIV negative, but
the virus has impacted her life. She currently supervises a biannual HIV/AIDS awareness week as
the director of the student health center at Pierce College, a
community commuter school in Woodland Hills, California.
Woman of the Month is supported by exclusive advertising from Gilead.
Overheard in the Women's Forum
"I think that it's OK to be angry. I am sometimes—it's natural—we are HIV positive. but I always try to not let myself stay there too long. Let yourself feel you are human. You should not beat yourself up about being angry."
